{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:33:17Z","timestamp":1790706797404,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Development, Promotion, and Application Project of Appropriate Medical and Healthcare Technologies of Guangxi","award":["S2022022"],"award-info":[{"award-number":["S2022022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03819-y","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:04:23Z","timestamp":1762250663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrating single-cell transcriptomics and machine learning reveals 4-aminobiphenyl exposure signatures and novel diagnostic biomarkers in bladder cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Yangyang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"2024","key":"3819_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics. Cancer J Clin. 2024;74(2024):12\u201349.","journal-title":"Cancer J Clin"},{"key":"3819_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"key":"3819_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ccell.2021.04.012","volume":"39","author":"M Knowles","year":"2021","unstructured":"Knowles M, Dyrskj\u00f8t L, Heath EI, Bellmunt J, Siefker-Radtke AO. Metastatic urothelial carcinoma. Cancer Cell. 2021;39:583\u20135.","journal-title":"Cancer Cell"},{"issue":"2","key":"3819_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84(2):176\u201390.","journal-title":"Eur Urol"},{"key":"3819_CR5","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/carcin\/bgq183","volume":"31","author":"Y Ding","year":"2010","unstructured":"Ding Y, Paonessa JD, Randall KL, Argoti D, Chen L, Vouros P, Zhang Y. Sulforaphane inhibits 4-aminobiphenyl-induced DNA damage in bladder cells and tissues. Carcinogenesis. 2010;31:1999\u20132003.","journal-title":"Carcinogenesis"},{"key":"3819_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mrrev.2016.03.004","volume":"768","author":"G Chappell","year":"2016","unstructured":"Chappell G, Pogribny IP, Guyton KZ, Rusyn I. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: a systematic literature review, mutation research. Rev Mutat Res. 2016;768:27\u201345.","journal-title":"Rev Mutat Res"},{"key":"3819_CR7","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00204-021-03059-3","volume":"95","author":"M Bellamri","year":"2021","unstructured":"Bellamri M, Brandt K, Brown CV, Wu MT, Turesky RJ. Cytotoxicity and genotoxicity of the carcinogen aristolochic acid I (AA-I) in human bladder RT4 cells. Arch Toxicol. 2021;95:2189\u201399.","journal-title":"Arch Toxicol"},{"key":"3819_CR8","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.18632\/oncotarget.1954","volume":"5","author":"HW Lee","year":"2014","unstructured":"Lee HW, Wang HT, Weng MW, Hu Y, Chen WS, Chou D, et al. Acrolein- and 4-aminobiphenyl-DNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cells. Oncotarget. 2014;5:3526\u201340.","journal-title":"Oncotarget"},{"key":"3819_CR9","first-page":"1139","volume-title":"Personal hair dye use and the risk of bladder cancer: a case-control study from the Netherlands","author":"MM Ros","year":"2012","unstructured":"Ros MM, Gago-Dominguez M, Aben KK, Bueno-de-Mesquita HB, Kampman E, Vermeulen SH, Kiemeney LA. Personal hair dye use and the risk of bladder cancer: a case-control study from the Netherlands. Volume 23. Cancer causes & control: CCC; 2012. pp. 1139\u201348."},{"key":"3819_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/jhep.2000.9197","volume":"32","author":"R Banerjee","year":"2000","unstructured":"Banerjee R, Caruccio L, Zhang YJ, McKercher S, Santella RM. Effects of carcinogen-induced transcription factors on the activation of hepatitis B virus expression in human hepatoblastoma HepG2 cells and its implication on hepatocellular carcinomas. Hepatology (Baltimore MD). 2000;32:367\u201374.","journal-title":"Hepatology (Baltimore MD)"},{"key":"3819_CR11","doi-asserted-by":"publisher","first-page":"152546","DOI":"10.1016\/j.tox.2020.152546","volume":"442","author":"D Hanna","year":"2020","unstructured":"Hanna D, Sugamori KS, Bott D, Grant DM. The impact of sex on hepatotoxic, inflammatory and proliferative responses in mouse models of liver carcinogenesis. Toxicology. 2020;442:152546.","journal-title":"Toxicology"},{"key":"3819_CR12","first-page":"287","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice, nature reviews. Clin Oncol. 2023;20:287\u2013304.","journal-title":"Clin Oncol"},{"key":"3819_CR13","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y. Bladder cancer, nature reviews. Disease Primers. 2017;3:17022.","journal-title":"Disease Primers"},{"key":"3819_CR14","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s00204-019-02486-7","volume":"93","author":"M Bellamri","year":"2019","unstructured":"Bellamri M, Yao L, Bonala R, Johnson F, Von Weymarn LB, Turesky RJ. Bioactivation of the tobacco carcinogens 4-aminobiphenyl (4-ABP) and 2-amino-9H-pyrido[2,3-b]indole (A\u03b1C) in human bladder RT4 cells. Arch Toxicol. 2019;93:1893\u2013902.","journal-title":"Arch Toxicol"},{"key":"3819_CR15","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1158\/1055-9965.EPI-08-0613","volume":"18","author":"MJ Van Hemelrijck","year":"2009","unstructured":"Van Hemelrijck MJ, Michaud DS, Connolly GN, Kabir Z. Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two meta-analyses. Cancer Epidemiol Biomarkers Prev. 2009;18:1312\u201320.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3819_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1158\/1940-6207.CAPR-11-0309","volume":"5","author":"JI Yoon","year":"2012","unstructured":"Yoon JI, Kim SI, Tommasi S, Besaratinia A. Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice. Cancer Prev Res (Philadelphia Pa). 2012;5:299\u2013308.","journal-title":"Cancer Prev Res (Philadelphia Pa)"},{"key":"3819_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/biom14040438","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ma H, Gao Y, Liang Y, Du Y, Hao S, Ni T. The tumor microenvironment: signal transduction. Biomolecules. 2024;14:438.","journal-title":"Biomolecules"},{"issue":"2019","key":"3819_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11122002","volume":"11","author":"KL Owen","year":"2019","unstructured":"Owen KL, Brockwell NK, Parker BS. Jak-STAT signaling: a double-edged sword of immune regulation and cancer progression. Cancers (Basel). 2019;11(2019):2002.","journal-title":"Cancers (Basel)"},{"key":"3819_CR19","doi-asserted-by":"crossref","unstructured":"Shiota M, Ushijima M, Tsukahara S, Nagakawa S, Okada T, Tanegashima T, Kobayashi S, Matsumoto T, Eto M. Oxidative stress in peroxisomes induced by androgen receptor Inhibition through peroxisome proliferator-activated receptor promotes enzalutamide resistance in prostate cancer, vol 221. Free radical biology & medicine; 2024. p. 81\u20138.","DOI":"10.1016\/j.freeradbiomed.2024.05.030"},{"key":"3819_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1160\/TH14-06-0497","volume":"113","author":"C Colasante","year":"2015","unstructured":"Colasante C, Chen J, Ahlemeyer B, Baumgart-Vogt E. Peroxisomes in cardiomyocytes and the peroxisome \/ peroxisome proliferator-activated receptor-loop. Thromb Haemost. 2015;113:452\u201363.","journal-title":"Thromb Haemost"},{"key":"3819_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-01853-6","volume":"40","author":"S Li","year":"2021","unstructured":"Li S, Shao J, Lou G, Wu C, Liu Y, Zheng M. MiR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway. J Exp Clin Cancer Res. 2021;40:53.","journal-title":"J Exp Clin Cancer Res"},{"key":"3819_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000090984","volume":"69","author":"ME Buim","year":"2005","unstructured":"Buim ME, Soares FA, Sarkis AS, Nagai MA. The transcripts of SFRP1, CEP63 and EIF4G2 genes are frequently downregulated in transitional cell carcinomas of the bladder. Oncology. 2005;69:445\u201354.","journal-title":"Oncology"},{"key":"3819_CR23","doi-asserted-by":"publisher","first-page":"165530","DOI":"10.1016\/j.scitotenv.2023.165530","volume":"898","author":"B \u00c1lvarez-Gonz\u00e1lez","year":"2023","unstructured":"\u00c1lvarez-Gonz\u00e1lez B, Porras-Quesada P, Arenas-Rodr\u00edguez V, Tamayo-G\u00f3mez A, V\u00e1zquez-Alonso F, Mart\u00ednez-Gonz\u00e1lez LJ, Hern\u00e1ndez AF. \u00c1lvarez-Cubero, genetic variants of antioxidant and xenobiotic metabolizing enzymes and their association with prostate cancer: A meta-analysis and functional in Silico analysis. Sci Total Environ. 2023;898:165530.","journal-title":"Sci Total Environ"},{"key":"3819_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s44320-024-00072-3","volume":"20","author":"R Cortez Cardoso Penha","year":"2024","unstructured":"Cortez Cardoso Penha R, Sexton Oates A, Senkin S, Park HA, Atkins J, Holcatova I, et al. Understanding the biological processes of kidney carcinogenesis: an integrative multi-omics approach. Mol Syst Biol. 2024;20:1282\u2013302.","journal-title":"Mol Syst Biol"},{"key":"3819_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101950","volume":"41","author":"D Ross","year":"2021","unstructured":"Ross D, Siegel D. The diverse functionality of NQO1 and its roles in redox control. Redox Biol. 2021;41:101950.","journal-title":"Redox Biol"},{"key":"3819_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/019262338201000234","volume":"10","author":"E Farber","year":"1982","unstructured":"Farber E. The biology of carcinogen-induced hepatocyte nodules and related liver lesions in the rats (1). Toxicol Pathol. 1982;10:197\u2013201.","journal-title":"Toxicol Pathol"},{"key":"3819_CR27","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1097\/JS9.0000000000001516","volume":"110","author":"J Li","year":"2024","unstructured":"Li J, Kong Z, Qi Y, Wang W, Su Q, Huang W, Zhang Z, Li S, Du E. Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8\u2009+\u2009T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics study. Int J Surg (London England). 2024;110:4911\u201331.","journal-title":"Int J Surg (London England)"},{"key":"3819_CR28","doi-asserted-by":"publisher","first-page":"1326509","DOI":"10.3389\/fimmu.2023.1326509","volume":"14","author":"X Shi","year":"2023","unstructured":"Shi X, Peng X, Chen Y, Shi Z, Yue C, Zuo L, Zhang L, Gao S. Overexpression of MTHFD2 represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer. Front Immunol. 2023;14:1326509.","journal-title":"Front Immunol"},{"key":"3819_CR29","doi-asserted-by":"publisher","first-page":"1491808","DOI":"10.3389\/fimmu.2024.1491808","volume":"15","author":"L Zhu","year":"2024","unstructured":"Zhu L, Xiao F, Hou Y, Huang S, Xu Y, Guo X, Dong X, Xu C, Zhang X, Gu H. Identification of anoikis-related molecular patterns and the novel risk model to predict prognosis, tumor microenvironment infiltration and immunotherapy response in bladder cancer. Front Immunol. 2024;15:1491808.","journal-title":"Front Immunol"},{"key":"3819_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-024-02191-9","volume":"24","author":"BH Jenkins","year":"2025","unstructured":"Jenkins BH, Tracy I, Rodrigues M, Smith MJL, Martinez BR, Edmond M, et al. Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response. Mol Cancer. 2025;24:3.","journal-title":"Mol Cancer"},{"key":"3819_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05939-5","volume":"22","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Xiong S, Gao J, Zhang Y, Guo E, Huang Y. C3(+) cancer-associated fibroblasts promote tumor growth and therapeutic resistance in gastric cancer via activation of the NF-\u03baB signaling pathway. J Transl Med. 2024;22:1130.","journal-title":"J Transl Med"},{"key":"3819_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.798474","volume":"12","author":"W Zhang","year":"2021","unstructured":"Zhang W, Kong Y, Li Y, Shi F, Lyu J, Sheng C, et al. Novel molecular determinants of response or resistance to immune checkpoint inhibitor therapies in melanoma. Front Immunol. 2021;12:798474.","journal-title":"Front Immunol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03819-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:04:27Z","timestamp":1762250667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03819-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3819"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03819-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used in this study were obtained from public databases, therefore no additional ethical certification was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2023"}}